Jincheng Yang Selected Research

Jincheng Yang Research Topics

Disease

11	Neoplasms (Cancer) 04/2023 - 01/2017
4	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2018
3	Infections 01/2020 - 11/2014
2	Drug-Related Side Effects and Adverse Reactions 10/2019 - 06/2019
2	Neoplasm Metastasis (Metastasis) 12/2018 - 10/2018
2	Breast Neoplasms (Breast Cancer) 10/2018 - 08/2018
2	Edema (Dropsy) 12/2011 - 04/2011
1	Febrile Seizures (Febrile Seizure) 01/2024
1	Neuroinflammatory Diseases 01/2024
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2022
1	Stomach Neoplasms (Stomach Cancer) 12/2022
1	Aneurysm (Aneurysms) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Hyperglycemia 01/2022
1	Neutropenia 01/2021
1	Congenital Abnormalities (Deformity) 01/2020
1	Alopecia (Baldness) 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Meningocele 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2019
1	Hemolysis 01/2018
1	Kyphosis 01/2017
1	Abscess 01/2017
1	Hypertrophy 01/2017
1	Osteoarthritis 01/2017
1	Spinal Tuberculosis (Pott's Disease) 01/2017
1	Pulmonary Hypertension 07/2015
1	Sepsis (Septicemia) 11/2014
1	Hepatitis 12/2011
1	Wounds and Injuries (Trauma) 12/2011

Drug/Important Bio-Agent (IBA)

4	AlbuminsIBA 11/2018 - 08/2018
4	Paclitaxel (Taxol)FDA LinkGeneric 11/2018 - 01/2018
3	LigandsIBA 01/2022 - 01/2018
3	ProdrugsIBA 11/2018 - 08/2018
3	DisulfidesIBA 10/2018 - 01/2018
3	maleimideIBA 10/2018 - 08/2018
2	CytokinesIBA 01/2021 - 11/2014
2	Antineoplastic Agents (Antineoplastics)IBA 10/2019 - 12/2018
2	Glucose (Dextrose)FDA LinkGeneric 06/2019 - 01/2018
2	Monoamine Oxidase (MAO)IBA 12/2018 - 10/2018
2	Coloring Agents (Dyes)IBA 12/2018 - 10/2018
2	MicroRNAs (MicroRNA)IBA 01/2017 - 11/2014
2	CarrageenanIBA 12/2011 - 04/2011
1	Serotonin (5 Hydroxytryptamine)IBA 01/2024
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2024
1	CamptothecinIBA 04/2023
1	Everolimus FDA Link 02/2023
1	palbociclibIBA 02/2023
1	trametinibIBA 02/2023
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022
1	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2022
1	Infliximab (Remicade)FDA Link 01/2022
1	InterleukinsIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	celastrolIBA 01/2022
1	Chloramphenicol (Chloromycetin)FDA Link 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	Long Noncoding RNAIBA 01/2020
1	Ceftazidime (Fortum)FDA LinkGeneric 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2019
1	dapagliflozinIBA 06/2019
1	CanagliflozinIBA 06/2019
1	SodiumIBA 06/2019
1	empagliflozinIBA 06/2019
1	Metformin (Glucophage)FDA LinkGeneric 06/2019
1	AnionsIBA 12/2018
1	Isoniazid (Ftivazide)FDA LinkGeneric 12/2018
1	Peptides (Polypeptides)IBA 12/2018
1	Antitubercular AgentsIBA 12/2018
1	Sulfides (Thioethers)IBA 10/2018
1	EnzymesIBA 10/2018
1	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2018
1	Docetaxel (Taxotere)FDA Link 10/2018
1	Hormones (Hormone)IBA 10/2018
1	Protein CoronaIBA 08/2018
1	Liposomes (Liposome)IBA 01/2018
1	AntigensIBA 01/2018
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2018
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2017
1	Matrilin ProteinsIBA 01/2017
1	Cytotoxins (Cytolysins)IBA 01/2017
1	Drug CombinationsIBA 01/2017
1	Caveolin 1IBA 07/2015
1	Proteins (Proteins, Gene)FDA Link 07/2015
1	ChemokinesIBA 11/2014
1	Concanavalin AIBA 12/2011

Therapy/Procedure

8	Therapeutics 02/2023 - 01/2018
4	Drug Therapy (Chemotherapy) 01/2021 - 08/2018
2	Oral Administration 06/2011 - 04/2011
1	Radiotherapy 12/2022
1	Injections 01/2022
1	Osteotomy 01/2020
1	X-Ray Film 01/2017
1	Debridement 01/2017